Nature’s Sunshine Products (NATR) Scheduled to Post Earnings on Thursday

Nature’s Sunshine Products (NASDAQ:NATR) is scheduled to announce its earnings results after the market closes on Thursday, November 7th. Nature’s Sunshine Products has set its FY 2024 guidance at EPS.Persons that are interested in registering for the company’s earnings conference call can do so using this link.

Nature’s Sunshine Products (NASDAQ:NATR) last issued its quarterly earnings data on Thursday, August 8th. The company reported $0.07 EPS for the quarter, missing analysts’ consensus estimates of $0.25 by ($0.18). The firm had revenue of $110.55 million during the quarter. Nature’s Sunshine Products had a net margin of 3.50% and a return on equity of 9.79%.

Nature’s Sunshine Products Price Performance

NATR stock opened at $12.99 on Thursday. The business’s fifty day moving average price is $13.37 and its two-hundred day moving average price is $15.01. The stock has a market capitalization of $243.30 million, a price-to-earnings ratio of 15.62 and a beta of 0.87. Nature’s Sunshine Products has a fifty-two week low of $10.81 and a fifty-two week high of $21.72.

Analyst Ratings Changes

NATR has been the subject of a number of recent research reports. Canaccord Genuity Group began coverage on shares of Nature’s Sunshine Products in a report on Friday, September 13th. They issued a “buy” rating and a $18.00 price objective for the company. DA Davidson cut their price target on Nature’s Sunshine Products from $23.00 to $21.00 and set a “buy” rating for the company in a research note on Monday, August 12th. StockNews.com upgraded Nature’s Sunshine Products from a “buy” rating to a “strong-buy” rating in a research note on Tuesday, September 10th. Finally, Canaccord Genuity Group assumed coverage on Nature’s Sunshine Products in a research report on Friday, September 13th. They set a “buy” rating and a $18.00 target price for the company.

Insider Transactions at Nature’s Sunshine Products

In other Nature’s Sunshine Products news, major shareholder Fosun Pharmaceutical Shanghai sold 3,000 shares of the business’s stock in a transaction that occurred on Thursday, October 10th. The shares were sold at an average price of $13.39, for a total transaction of $40,170.00. Following the completion of the transaction, the insider now directly owns 69,347 shares in the company, valued at $928,556.33. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. In the last 90 days, insiders sold 7,499 shares of company stock valued at $99,802. Company insiders own 4.70% of the company’s stock.

Nature’s Sunshine Products Company Profile

Nature’s Sunshine Products, Inc, a natural health and wellness company, manufactures and sells nutritional and personal care products in Asia, Europe, North America, Latin America, and internationally. It offers general health products related to blood sugar support, bone health, cellular health, cognitive function, joint health, mood, sexual health, sleep, sports and energy, and vision.